Brian Daniel Webster - 06 Mar 2025 Form 3 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Reporting relationship: President and Chief Executive Officer, Director
Issuer ticker: KMTS
Reported as of: 06 Mar 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 06 Mar 2025, 21:02:45 UTC
Next SEC filing: 21 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Brian Webster

Key filing fact

Brian Daniel Webster filed Form 3 for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) on 06 Mar 2025.

Key facts

This page summarizes Brian Daniel Webster's Form 3 filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Mar 2025, 21:02.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KMTS holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 309,342
Date: 06 Mar 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KMTS holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 06 Mar 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 1,780,000
Exercise price: $17.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 1,068,000 fully vested options and 712,000 options that will vest as follows: 356,000 of such options will vest on March 6, 2026, and the remaining 356,000 will vest monthly over the following year.

SEC remarks

President and Chief Executive Officer